Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: Identification of key factors using artificial neural networks

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Coppedè, Fabio ^a   Grossi, Enzo ^b,c   Migheli, Francesca ^a   Migliore, Lucia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Bracco Medical Department   (Italy)

^c Semeion centro ricerche di scienze della communicazione   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE; FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ACCURACY; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL NEURAL NETWORK; CAUCASIAN; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOGENETICS; DNA POLYMORPHISM; DOWN SYNDROME; FEMALE; FOLATE METABOLISM; GENE DELETION; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; ITALY; MOTHER; MULTINUCLEAR CELL; PERCEPTRON; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; AREA UNDER THE CURVE; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MICRONUCLEUS; RISK;

AREA UNDER CURVE; DATABASES, GENETIC; DOWN SYNDROME; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; ITALY; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEURAL NETWORKS (COMPUTER); POLYMORPHISM, GENETIC; RISK;

EID: 77956908693     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-42     Document Type: Article

References (35)

1. Folate metabolism and requirements. LB Bailey JF Gregory, J Nutr 1999 129 779 82 10203550
2. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. F Coppedè Mutat Res 2009 682 54 70 10.1016/j.mrrev. 2009.06.001 19524060
3. The role of folic acid and Vitamin B12 in genomic stability of human cells. M Fenech, Mutat Res 2001 475 57 67 11295154
4. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. SJ James M Pogribna IP Pogribny S Melnyk RJ Hine JB Gibson P Yi DL Tafoya DH Swenson VL Wilson DW Gaylor, Am J Clin Nutr 1999 70 495 501 10500018
5. Double aneuploidy (48, XXY, +21) of maternal origin in a child born to a 13-year-old mother: evaluation of the maternal folate metabolism. JM Biselli FB Machado BL Zampieri AF Alves da Silva EM Goloni-Bertollo R Haddad MN Eberlin H Vannucchi VM Carvalho E Medina-Acosta EC Pavarino-Bertelli, Genet Couns 2009 20 225 34 19852428
6. Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. AP Brandalize E Bandinelli PA dos Santos I Roisenberg L Schüler-Faccini, Am J Med Genet A 2009 149A 2080 7 10.1002/ajmg.a.32989 19725133
7. Investigation of CBS, MTR, RFC-1 and TC polymorphisms as maternal risk factors for Down syndrome. N Fintelman-Rodrigues JC Corra JM Santos MM Pimentel CB Santos-Rebouças, Dis Markers 2009 26 155 61 19729796
8. Investigating the impact of the Down syndrome related common MTHFR 677C>T polymorphism in the Danish population. H Kokotas M Grigoriadou M Mikkelsen A Giannoulia-Karantana MB Petersen, Dis Markers 2009 27 279 85 20075510
9. Folate metabolism and the risk of Down syndrome. D Patterson, Downs Syndr Res Pract 2008 12 93 7 10.3104/updates.2051 19026278
10. Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. E Zintzaras, J Hum Genet 2007 52 943 53 10.1007/s10038-007-0202-x 17934692
11. Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. L Migliore G Boni R Bernardini F Trippi R Colognato I Fontana F Coppedè I Sbrana, Neurobiol Aging 2006 27 710 6 10.1016/j.neurobiolaging.2005.03.025 16005550
12. On the origin of the maternal age effect in trisomy 21 Down syndrome: the Oocyte Mosaicism Selection model. MA Hultén S Patel J Jonasson E Iwarsson, Reproduction 2010 139 1 9 10.1530/REP-09-0088 19755486
13. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. F Coppedè R Colognato A Bonelli G Astrea S Bargagna G Siciliano L Migliore, Am J Med Genet A 2007 143A 2006 15 10.1002/ajmg.a.31886 17702010
14. Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring. F Coppedè F Migheli S Bargagna G Siciliano I Antonucci L Stuppia G Palka L Migliore, Neurosci Lett 2009 449 15 9 10.1016/j.neulet.2008.10.074 18983896
15. Assessment of the Role of Genetic Polymorphism in Venous Thrombosis Through Artificial Neural Networks. S Penco E Grossi S Cheng M Intraligi G Maurelli MC Patrosso A Marocchi M Buscema, Annals of Human Genetics 2005 69 693 706 10.1111/j.1529-8817.2005.00206.x 16266408
16. A review of evidence of health benefit from artificial neural networks in medical intervention. PJC Lisboa, Neural Networks 2002 15 11 39 10.1016/S0893-6080(01)00111-3 11958484
17. International experience on the use of artificial neural networks in gastroenterology. E Grossi A Mancini M Buscema, Dig Liver Dis 2007 39 278 85 10.1016/j.dld.2006.10.003 17275425
18. Artificial Neural Networks Identify the Predictive Values of Risk Factors on the Conversion of Amnestic Mild Cognitive Impairment. M Tabaton P Odetti S Cammarata R Borghi F Monacelli C Caltagirone P Boss M Buscema E Grossi, J Alzheimers Dis 2010 19 1035 40 20157257
19. Placental determinants of fetal growth: identification of key factors in the insulin-like growth factor and cytokine systems using artificial neural networks. ME Street E Grossi C Volta E Faleschini S Bernasconi, BMC Pediatr 2008 8 24 10.1186/1471-2431-8-24 18559101
20. New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. S Penco M Buscema MC Patrosso A Marocchi E Grossi, BMC Bioinformatics 2008 9 254 10.1186/1471-2105-9-254 18513389
21. Neuropathological findings processed by artificial neural networks (ANNs) can perfectly distinguish Alzheimer's patients from controls in the Nun Study. E Grossi MP Buscema D Snowdon P Antuono, BMC Neurol 2007 7 15 10.1186/1471-2377-7-15 17584929
22. An optimized experimental protocol based on neuro-evolutionary algorithms application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment. M Buscema E Grossi M Intraligi N Garbagna A Andriulli M Breda, Artif Intell Med 2005 34 279 305 10.1016/j.artmed.2004.12.001 16023564
23. DE Rumelhart Mc Clelland JL Parallel, Distributed Processing: Explorations in the Microstructure of Cognition Cambridge, MA: Foundations, MIT Press 1986 1
24. Genetic Doping Algorihm (GenD): theory and applications. M Buscema, Expert Systems 2004 21 63 79 10.1111/j.1468-0394.2004.00264.x
25. The implicit function as squashing time model: a novel parallel nonlinear EEG analysis technique distinguishing mild cognitive impairment and Alzheimer's disease subjects with high degree of accuracy. M Buscema M Capriotti F Bergami C Babiloni P Rossini E Grossi, Comput Intell Neurosci 2007 35021 1 15 10.1155/2007/35021
26. The semantic connectivity map: an adapting self-organising knowledge discovery method in data bases. Experience in gastro-oesophageal reflux disease. M Buscema E Grossi, Int J Data Min Bioinform 2008 2 362 404 10.1504/IJDMB.2008.022159 19216342
27. Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer disease. M Buscema E Grossi D Snowdon P Antuono, Curr Alzheimer Res 2008 5 481 98 10.2174/156720508785908928 18855590
28. Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms. TG Dietterich, Neural Comput 1998 10 1895 1923 10.1162/089976698300017197 9744903
29. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. K Yamada Z Chen R Rozen RG Matthews, Proc Natl Acad Sci USA 2001 98 14853 14858 10.1073/pnas.261469998 11742092
30. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. CF Skibola MS Forrest F Coppedè L Agana A Hubbard MT Smith PM Bracci EA Holly, Blood 2004 104 2155 2162 10.1182/blood-2004-02-0557 15198953
31. Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women. F Coppedè G Marini S Bargagna L Stuppia F Minichilli I Fontana R Colognato G Astrea G Palka L Migliore, Am J Med Genet A 2006 140 1083 1091 16596679
32. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. I Scala B Granese M Sellitto S Salomè A Sammartino A Pepe P Mastroiacovo G Sebastio G Andria, Genet Med 2006 8 409 416 10.1097/01.gim.0000228206.21793.82 16845273
33. Response to ''folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women'' by F. Coppedè et al. (2006). I Scala B Granese A Lisi P Mastroiacovo G Andria, Am J Med Genet A 2007 143 1015 1017
34. MTHFR and RFC-1 gene polymorphisms and the risk of Down syndrome in Italy. F Coppedè R Colognato L Migliore, Am J Med Genet A 2007 143 1018 1019
35. Methionine synthase (MTR) 2756 (A>G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. P Bosco RM Gueant-Rodriguez G Anello C Barone F Namour F Caraci A Roman C Romano JL Gueant, Am J Med Genet A 2003 121 219 224 10.1002/ajmg.a.20234